C-Myb Enhances Breast Cancer Invasion And Metastasis Through The Wnt/Beta-Catenin/Axin2 Pathway

Yihao Li,Ke Jin,Gabi W van Pelt,Hans van Dam,Xiao Yu,Wilma E Mesker,Peter Ten Dijke,Fangfang Zhou,Long Zhang
DOI: https://doi.org/10.1158/0008-5472.CAN-15-2302
IF: 11.2
2016-01-01
Cancer Research
Abstract:The molecular underpinnings of aggressive breast cancers remain mainly obscure. Here we demonstrate that activation of the transcription factor c-Myb is required for the prometastatic character of basal breast cancers. An analysis of breast cancer patients led us to identify c-Myb as an activator of Wnt/beta-catenin signaling. c-Myb interacted with the intracellular Wnt effector beta-catenin and coactivated the Wnt/beta-catenin target genes Cyclin D1 and Axin2. Moreover, c-Myb controlled metastasis in an Axin2-dependent manner. Expression microarray analyses revealed a positive association between Axin2 and c-Myb, a target of the proinflammatory cytokine IL1 beta that was found to be required for IL1 beta-induced breast cancer cell invasion. Overall, our results identified c-Myb as a promoter of breast cancer invasion and metastasis through its ability to activate Wnt/beta-catenin/Axin2 signaling. (C) 2016 AACR.
What problem does this paper attempt to address?